Advanced/recurrent ovarian cancer

Clinical trials for Advanced/recurrent ovarian cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced/recurrent ovarian cancer trials appear

Sign up with your email to follow new studies for Advanced/recurrent ovarian cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Ovarian cancer drug study pulled before it even started

Disease control Cancelled

This study aimed to test new cancer drugs, alone or in combination, for people with advanced or recurrent ovarian cancer. The treatments were chosen based on specific genetic markers in each person's tumor. However, the study was withdrawn before enrolling any participants, so no…

Matched conditions: ADVANCED/RECURRENT OVARIAN CANCER

Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

Advanced/recurrent ovarian cancer

Get alerted when new Advanced/recurrent ovarian cancer trials appear

Ovarian cancer drug study pulled before it even started